Common Shares Outstanding: The number of class A shares currently held by investors.
Insight Molecular Diagnostics Inc. (IMDX) had Common Shares Outstanding of 28.68M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.05M |
|
$-50.22M |
|
$1.76M |
|
$2.30M |
|
$55.18M |
|
$-51.12M |
|
$0.90M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-51.12M |
|
$-48.93M |
|
30.48M |
|
30.48M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$15.31M |
|
$6.43M |
|
$10.45M |
|
$25.76M |
|
$12.07M |
|
$45.15M |
|
$45.15M |
|
$57.22M |
|
$-31.46M |
|
$-31.46M |
|
$-31.46M |
|
|
Common Shares Outstanding |
28.68M |
| Cash Flow Statement Financials | |
$-22.18M |
|
$-3.19M |
|
$28.07M |
|
$10.34M |
|
$12.92M |
|
$2.58M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
3.30 |
|
-1.43 |
|
56.67% |
|
-1260.77% |
|
-1260.77% |
|
-1206.59% |
|
-1238.52% |
|
-1238.52% |
|
$-25.37M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
3.94 |
|
3.59 |
|
101.53 |
|
159.62% |
|
159.62% |
|
-194.99% |
|
-367.09% |
|
$-1.10 |
|
$-0.83 |
|
$-0.73 |
|